Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 2001, p. 1511-1514, Vol. 45, No. 5
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.5.1511-1514.2001
Antibiotic Susceptibilities of Genetically
Characterized Streptococcus milleri Group Strains
Michael
Tracy,
Anna
Wanahita,
Yevgeny
Shuhatovich,
Elizabeth A.
Goldsmith,
Jill E.
Clarridge III, and
Daniel M.
Musher*
Medical and Laboratory Services, Veterans
Affairs Medical Center, and the Departments of Medicine, Molecular
Virology, and Pathology, Baylor College of Medicine, Houston, Texas
77030
Received 27 October 2000/Returned for modification 18 December
2000/Accepted 15 February 2001
 |
ABSTRACT |
Previous studies of the antibiotic susceptibility of
Streptococcus milleri group organisms have distinguished
among species by using phenotypic techniques. Using 44 isolates that
were speciated by 16S rRNA gene sequencing, we studied the MICs and
minimum bactericidal concentrations of penicillin, ampicillin,
ceftriaxone, and clindamycin for Streptococcus intermedius,
Streptococcus constellatus, and Streptococcus
anginosus. None of the organisms was resistant to beta-lactam
antibiotics, although a few isolates were intermediately resistant; one
strain of S. anginosus was tolerant to ampicillin, and
another was tolerant to ceftriaxone. Six isolates were resistant to
clindamycin, with representation from each of the three species. Relatively small differences in antibiotic susceptibilities among species of the S. milleri group show that speciation is
unlikely to be important in selecting an antibiotic to treat infection caused by one of these isolates.
 |
INTRODUCTION |
Three species compose the
Streptococcus milleri group: Streptococcus
intermedius, Streptococcus constellatus, and Streptococcus anginosus (5, 12, 13). Investigators who have used
phenotypically differentiated strains within the S. milleri
group have suggested that these three species have similar antibiotic
susceptibilities (1, 4, 7, 8). Phenotypic identification
to the species level, however, has been shown to be difficult and at
times unreliable (3, 6, 9). In order to compare the
antibiotic susceptibilities of species within the S. milleri
group, we determined the MICs and minimum bactericidal concentrations
(MBCs) of four clinically relevant antibiotics for 44 genotypically
characterized strains of the S. milleri group.
 |
MATERIALS AND METHODS |
Bacteria.
Forty-four clinically significant isolates of the
S. milleri group that had been isolated from different
patients between 1985 and 2000 were studied. All had been implicated as
the causative organisms in infection (2). Their sources of
isolation are summarized in Table 1.
These strains were assigned to the S. milleri group based on
the results of API 20 Strep system (bioMérieux Vitek, Hazelton,
Mo.) tests and were further speciated by PCR amplification and sequence
analysis of a segment of the 16S rRNA gene (3). They were
stored at
70°C after having been passaged no more than two or three
times. In addition to two well-characterized strains of
Streptococcus pneumoniae that have been studied repeatedly in our laboratory, the following American Type Culture Collection (ATCC) strains were included as reference strains: ATCC 27335 (S.
intermedius), ATCC 9895 and ATCC 33397 (S. anginosus),
and ATCC 29213 (Staphylococcus aureus).
MIC and MBC testing.
Todd-Hewitt broth (Difco, Detroit,
Mich.) containing 0.5% yeast extract (Difco) (THY), a broth medium
previously shown by our laboratory to be optimal for testing the MICs
of S. pneumoniae (10), was used in this study.
Preliminary studies showed that this medium supported the growth of
S. milleri group isolates more reliably than Mueller-Hinton
or tryptic soy broth. Penicillin G (Sigma, St. Louis, Mo.), ampicillin
(Bristol-Myers Squibb, Princeton, N.J.), clindamycin (Sigma), and
ceftriaxone (Roche, Nutley, N.J.) were dissolved in sterile, distilled
H2O and then diluted in THY to yield 8 µg/ml. Serial
twofold dilutions in THY yielded concentrations from 8 to 0.008 µg/ml. Bacteria were added to yield about 106 CFU/ml, and
the tubes were incubated at 35°C in 5% CO2. MICs were
defined as the lowest antibiotic concentrations at which there was no
visible growth after 24 h of incubation. Subcultures of the last
cloudy tube and the next four clear tubes were made, and CFU were
counted after overnight incubation. MBC was defined as the lowest
antibiotic concentration for which there was
99% killing. The
geometric mean and median of the MIC and the MIC at which 90% of
isolates were inhibited (MIC90) were determined for each
antibiotic and for each isolate. Analogous values were calculated for
the MBC.
Susceptibility (S), intermediate resistance (IR), and resistance (R)
were defined in accord with NCCLS guidelines (11) as follows: penicillin, S
0.12, IR = 0.25 to 2, and R
4; ampicillin, S
0.25, IR = 0.5 to 4, and R
8;
ceftriaxone, S
0.5, IR = 1, and R
2; and
clindamycin, S
0.25, IR = 0.5, and R
1.
Statistical analysis.
The geometric mean MIC and MBC of each
antibiotic were calculated for each bacterial species. When the MIC
readings fell outside the range of antibiotic dilutions (e.g., >8 or
<0.008 µg/ml), they were assigned the value of the next dilution in
the series (e.g., 16 or 0.004 µg/ml, respectively). The
Kruskal-Wallis test was used to determine whether there were
significant differences in susceptibility to each antibiotic among the
three bacterial species. The Mann-Whitney U test was used to make
pairwise comparisons of the MICs or MBCs between species. For all
tests,
was equal to 0.05.
 |
RESULTS |
As shown in Fig. 1, none of
12 S. intermedius, 16 S. constellatus, and 16 S. anginosus isolates was resistant to penicillin, ampicillin, or ceftriaxone. Four isolates exhibited intermediate resistance to penicillin, and four were intermediately resistant to
ampicillin; only one S. constellatus isolate was
intermediately resistant to both of these drugs. All isolates were
fully susceptible to ceftriaxone. In contrast, a total of six (14%)
isolates were resistant to clindamycin, including at least one of each
species studied.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 1.
MICs and MBCs of four antibiotics for S. intermedius, S. constellatus, and S. anginosus. Each
point indicates the MIC or MBC for an individual isolate.
|
|
Table 2 summarizes the
MIC50s, MIC90s, and geometric mean MICs.
S. intermedius had the lowest mean MIC and tended to have the lowest MIC90 and S. constellatus had the
highest mean MIC and tended to have the highest MIC90 for
the three beta-lactam antibiotics. Differences among the species were
significant (P < 0.05; Kruskal-Wallis test); for
clindamycin, significant differences were not observed (P = 0.09).
Similar results were obtained when the MBCs of each antibiotic for each
bacterial species were compared, but the interspecies differences were
even greater (P
0.03 for the beta-lactams; P < 0.05 for clindamycin) (Table
3). The great majority of strains exhibited no tolerance to beta-lactam antibiotics: in 55% of 132 reactions (three antibiotics tested against 44 bacterial strains), the
MIC was equal to the MBC, and in an additional 37%, there was only a
twofold difference. For all other isolates, the difference between the
MIC and the MBC was 4-fold, with the exception of two strains of
S. anginosus, one of which exhibited a 16-fold difference in
the case of ampicillin and another with a like difference for
ceftriaxone. The MBCs of penicillin, ampicillin, and ceftriaxone for
S. constellatus exceeded those for S. intermedius, and the MBC of ampicillin for S. constellatus was also greater than that for S. anginosus (P < 0.05 for all comparisons;
Mann-Whitney test). The MBC of clindamycin for S. anginosus
exceeded that for the other two species (P < 0.05;
Mann-Whitney test).
In order to determine whether there had been an increase in the
resistances of S. milleri group organisms to penicillin in recent years, the MIC of each of the four antibiotics for S. constellatus was plotted by year. This organism was selected
because the dates of isolation of the species spanned the full 15-year
period. Regression analysis revealed no tendency toward increased
resistance (r varied from
0.04 to 0.2, with
P values ranging from 0.45 to 0.96).
 |
DISCUSSION |
In this study, determination of MICs and MBCs for 44 genetically
characterized strains of the S. milleri group showed that all of the strains were susceptible to penicillin, ampicillin, or
ceftriaxone; at least one isolate from each species was resistant to
clindamycin. Although there were, in fact, statistically significant differences in susceptibility to beta-lactam antibiotics among the
three species studied, these differences were sufficiently small that
they would not be clinically relevant. Since none of the isolates was
resistant to any beta-lactam antibiotic and at least one isolate from
each species was resistant to clindamycin, precise identification to
the species level also does not help to predict antibiotic
susceptibility and therefore is not important in the initial selection
of antibiotic therapy. It is interesting to note that for >90% of the
strains, the MBC of beta-lactam antibiotics was
2 times the MIC;
tolerance was noted for only one isolate each with ampicillin and
ceftriaxone. Even though these organisms are usually cultured from
abscesses, and therefore infections caused by them are best treated
surgically, there are clinical situations in which surgical drainage is
difficult to accomplish, and it is useful to know that antibiotic
tolerance is not likely to be an issue.
Some authors have expressed concern that clindamycin resistance in the
S. milleri group is increasing (4, 7, 8). The
bacterial strains that we studied were isolated from patients over a
period of 2 decades, and there was no tendency for more recent isolates
to show higher levels of antimicrobial resistance.
Our data on antimicrobial susceptibility are consistent with the
division of the S. milleri group into three species, in that the finding of different susceptibilities, even though of no notable clinical significance, supports the speciation based on gene sequence analysis of RNA (3). Recent genetic studies have shown
that S. constellatus and S. intermedius are more
closely related to each other than either is to S. anginosus
(3, 6), in contrast to earlier studies that did not show
this as clearly (13). It may not be surprising that the
pattern of antibiotic susceptibilities does not follow this apparent
genetic relatedness, since acquisition of resistance is more recent and
is driven by other factors, such as the ecological niche and the
likelihood of prior exposure to antibiotics.
 |
ACKNOWLEDGMENTS |
Michael Tracy and Anna Wanahita participated equally in carrying
out the research and writing this report.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Infectious
Disease Section, Veterans Affairs Medical Center, Houston, TX 77030. Phone: (713) 794-7386. Fax: (713) 794-7045. E-mail:
daniel.musher{at}med.va.gov.
 |
REFERENCES |
| 1.
|
Bantar, C.,
L. Fernandez Canigia,
S. Relloso,
A. Lanza,
H. Bianchini, and I. Smayevsky.
1996.
Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens.
J. Clin. Microbiol.
34:2020-2022[Abstract].
|
| 2.
| Clarridge, J. E., III, S. Attori, D. M. Musher, J. Herbert, and S. Dunbar. S. intermedius, S. constellatus, and S. anginosus ("Streptococcus milleri group")
are of different clinical importance and not equally associated with
abscess. Clin. Infect. Dis., in press.
|
| 3.
|
Clarridge, J. E., III,
C. Osting,
M. Jalali,
J. Osborne, and M. Waddington.
1999.
Genotypic and phenotypic characterization of "Streptococcus milleri" group isolates from a Veteran's Administration hospital population.
J. Clin. Microbiol.
37:3681-3687[Abstract/Free Full Text].
|
| 4.
|
Gómez-Garcés, J.-L.,
J.-I. Alos, and R. Cogollos.
1994.
Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group.
Diagn. Microbiol. Infect Dis.
19:69-73[CrossRef][Medline].
|
| 5.
|
Jacobs, J. A.,
H. G. Pietersen,
E. E. Stobbringh, and P. B. Soeters.
1995.
Streptococcus anginosus, Streptococcus constellatus, and Streptococcus intermedius: clinical relevance, hemolytic, and serologic characteristics.
Am. J. Clin. Pathol.
104:547-553[Medline].
|
| 6.
|
Jacobs, J. A.,
C. S. Schot,
A. E. Bunschoten, and L. M. Schouls.
1996.
Rapid species identification of Streptococcus milleri strains by line blot hybridization: identification of a distinct 16S rRNA population closely related to Streptococcus constellatus.
J. Clin. Microbiol.
34:1717-1721[Abstract].
|
| 7.
|
Jacobs, J. A., and E. E. Stobberingh.
1996.
In-vitro antimicrobial susceptibility of the `Streptococcus milleri' group (Steptococcus anginosus, Streptococcus constellatus, and Streptococcus intermedius).
J. Antimicrob. Chemother.
37:371-375[Abstract/Free Full Text].
|
| 8.
|
Limia, A.,
M. L. Jimenez,
T. Alarcon, and M. Lopez-Brea.
1999.
Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group.
Eur. J. Microbiol. Infect. Dis.
18:440-444.
|
| 9.
|
Limia, A.,
M. L. Jimenez,
T. Alarcon, and M. Lopez-Brea.
2000.
Comparison of three methods for identification of Streptococcus milleri group isolates to species level.
Eur. J. Microbiol. Infect. Dis.
19:128-131.
|
| 10.
|
Marshall, K. J.,
D. M. Musher, and E. O. Mason.
1993.
Testing of Streptococcus pneumoniae for resistance to penicillin.
J. Clin. Microbiol.
31:1246-1250[Abstract/Free Full Text].
|
| 11.
|
National Committee for Clinical Laboratory Standards.
2000.
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standards, 5th ed., p. 36-37.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 12.
|
Whiley, R. A., and D. Beighton.
1991.
Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species.
Int. J. Syst. Bacteriol.
41:1-5[Abstract/Free Full Text].
|
| 13.
|
Whiley, R. A.,
B. Duke,
J. M. Hardie, and L. M. C. Hall.
1995.
Heterogenicity among 16S-23S rRNA intergenic spacers of species within the Streptococcus milleri group.
Microbiology
141:1461-1467[Abstract].
|
Antimicrobial Agents and Chemotherapy, May 2001, p. 1511-1514, Vol. 45, No. 5
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.5.1511-1514.2001
This article has been cited by other articles:
-
Ahmed, N. A. A. M., Petersen, F. C., Scheie, A. A.
(2007). AI-2 quorum sensing affects antibiotic susceptibility in Streptococcus anginosus. J Antimicrob Chemother
60: 49-53
[Abstract]
[Full Text]
-
Wargo, K. A, McConnell, V. J, Higginbotham, S. A
(2006). A Case of Streptococcus intermedius Empyema. The Annals of Pharmacotherapy
40: 1208-1210
[Abstract]
[Full Text]
-
Daley, P., Church, D. L., Gregson, D. B., Elsayed, S.
(2005). Species-Level Molecular Identification of Invasive "Streptococcus milleri" Group Clinical Isolates by Nucleic Acid Sequencing in a Centralized Regional Microbiology Laboratory. J. Clin. Microbiol.
43: 2987-2988
[Abstract]
[Full Text]
-
Upton, A., Drinkovic, D., Pottumarthy, S., West, T., Morris, A. J.
(2005). Culture results of heart valves resected because of streptococcal endocarditis: insights into duration of treatment to achieve valve sterilization. J Antimicrob Chemother
55: 234-239
[Abstract]
[Full Text]
-
Karchmer, A. W., Torchiana, D. F., Chae, C. U., Afridi, N. A., Houser, S. L.
(2004). Case 29-2004 - A 75-Year-Old Woman with Acute Onset of Chest Pain Followed by Fever. NEJM
351: 1240-1248
[Full Text]
-
Chen, C. C., Teng, L. J., Chang, T. C.
(2004). Identification of Clinically Relevant Viridans Group Streptococci by Sequence Analysis of the 16S-23S Ribosomal DNA Spacer Region. J. Clin. Microbiol.
42: 2651-2657
[Abstract]
[Full Text]
-
Chiang, W.-C., Tsai, J.-C., Chen, S.-Y., Hsu, C.-Y., Wu, C.-T., Teng, L.-J., Hsueh, P.-R.
(2004). Mycotic Aneurysm Caused by Streptococcus constellatus subsp. constellatus. J. Clin. Microbiol.
42: 1826-1828
[Abstract]
[Full Text]
-
Lefort, A., Lortholary, O., Casassus, P., Selton-Suty, C., Guillevin, L., Mainardi, J.-L., for the ss-Hemolytic Streptococci Infective Endoca,
(2002). Comparison Between Adult Endocarditis Due to {beta}-Hemolytic Streptococci (Serogroups A, B, C, and G) and Streptococcus milleri: A Multicenter Study in France. Arch Intern Med
162: 2450-2456
[Abstract]
[Full Text]
-
Facklam, R.
(2002). What Happened to the Streptococci: Overview of Taxonomic and Nomenclature Changes. Clin. Microbiol. Rev.
15: 613-630
[Abstract]
[Full Text]
-
Tyrrell, K. L., Citron, D. M., Jenkins, J. R., Goldstein, E. J. C.
(2002). Periodontal Bacteria in Rabbit Mandibular and Maxillary Abscesses. J. Clin. Microbiol.
40: 1044-1047
[Abstract]
[Full Text]
-
Jacobs, J. A., van Baar, G. J., London, N. H. H. J., Tjhie, J. H. T., Schouls, L. M., Stobberingh, E. E.
(2001). Prevalence of Macrolide Resistance Genes in Clinical Isolates of the Streptococcus anginosus (""S. milleri"") Group. Antimicrob. Agents Chemother.
45: 2375-2377
[Abstract]
[Full Text]